Related Experiment Video
Updated: Jan 20, 2026

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
Published on: July 17, 2019
MiR-135-5p promotes osteoblast differentiation by targeting HIF1AN in MC3T3-E1 cells
Nuo Yin1, Longzhang Zhu1, Liang Ding1
1Department of Orthopaedics, Shanghai Fengxian District Central Hospital, No. 6600, Nanfeng Highway, Shanghai, 201499 China.
Background:
MicroRNAs (miRNAs or miRs) serve crucial roles in the progression of osteoporosis. This study investigated the role and specific molecular mechanism of miR-135-5p in regulating osteoblast differentiation and calcification.
Methods:
Bone morphogenetic protein 2 (BMP2) was employed to interfere with the differentiation of MC3T3-E1. Then, miR-135-5p mimic or miR-135-5p inhibitor was transfected into MC3T3-E1, and quantitative RT-PCR was used to measure the expression of miR-135-5p. The expressions of runt-related transcription factor 2 (Runx2), osterix (OSX), osteopontin (OPN), and osteocalcin (OCN) were determined using western blot. Alkaline phosphatase (ALP) activity was measured using an appropriate kit assay. Calcium nodule staining was evaluated with alizarin red staining. A luciferase reporter assay was used to verify the target of miR-135-5p. Hypoxia-inducible factor 1 α inhibitor (HIF1AN) overexpression was applied to investigate its own role in the mechanism and a miR-135-5p rescue experiment was also performed.
Results:
Overexpression of miR-135-5p promoted osteogenic differentiation and calcification, as shown by the increase in ALP activity, calcification and osteogenic marker levels, including Runx2, OSX, OPN and OCN. Knockdown of miR-135-5p yielded the opposite results. HIF1AN was confirmed as a direct target of miR-135-5p. HIF1AN overexpression inhibited osteogenic differentiation and calcification while miR-135-5p reversed these effects.
Conclusions:
These results indicate that miR-135-5p might have a therapeutic application related to its promotion of bone formation through the targeting of HIF1AN.
Insights
MicroRNA-135-5p promotes bone formation by targeting HIF1AN, offering potential therapeutic applications for osteoporosis. This study elucidates the molecular mechanism of miR-135-5p in osteoblast differentiation and calcification.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- MicroRNAs (miRNAs) are key regulators in osteoporosis development.
- Osteoblast differentiation and calcification are critical processes in bone formation.
Purpose of the Study:
- To investigate the role of miR-135-5p in osteoblast differentiation and calcification.
- To elucidate the molecular mechanism underlying miR-135-5p's function.
Main Methods:
- MC3T3-E1 cells were treated with BMP2 and transfected with miR-135-5p mimic or inhibitor.
- Quantitative RT-PCR, Western blot, ALP activity assay, and alizarin red staining were used to assess osteogenic markers and calcification.
- Luciferase reporter assays and HIF1AN overexpression were employed to confirm the target and mechanism.
Main Results:
- Overexpression of miR-135-5p enhanced osteogenic differentiation and calcification, increasing ALP activity and levels of Runx2, OSX, OPN, and OCN.
- Knockdown of miR-135-5p inhibited these processes.
- HIF1AN was identified as a direct target of miR-135-5p; its overexpression inhibited osteogenesis, an effect reversed by miR-135-5p.
Conclusions:
- miR-135-5p promotes osteoblast differentiation and calcification by targeting HIF1AN.
- miR-135-5p demonstrates potential as a therapeutic agent for enhancing bone formation in conditions like osteoporosis.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
E1 Reaction: Kinetics and Mechanism
E1 Reaction: Stereochemistry and Regiochemistry
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
iPS Cell Differentiation

